Page last updated: 2024-11-04

rofecoxib and Anaphylactic Reaction

rofecoxib has been researched along with Anaphylactic Reaction in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Controlled oral challenge with nonsteroidal anti-inflammatory drugs (NSAIDs) is the only definite way to detect safe NSAIDs in patients with NSAID-induced anaphylactoid reactions."2.71Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs. ( Conde, J; Delgado, J; Florido, JF; López-Pascual, E; Nieto, MA; Ortega, N; Quiralte, J; Sáenz de San Pedro, B, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quiralte, J1
Delgado, J1
Sáenz de San Pedro, B1
López-Pascual, E1
Nieto, MA1
Ortega, N1
Florido, JF1
Conde, J1
Fontaine, C1
Bousquet, PJ1
Demoly, P1
Schellenberg, RR1
Isserow, SH1

Trials

1 trial available for rofecoxib and Anaphylactic Reaction

ArticleYear
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2004, Volume: 93, Issue:4

    Topics: Adult; Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Celecoxib; Cyclooxyge

2004

Other Studies

2 other studies available for rofecoxib and Anaphylactic Reaction

ArticleYear
Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole.
    The Journal of allergy and clinical immunology, 2005, Volume: 115, Issue:3

    Topics: Adult; Anaphylaxis; Anti-Infective Agents; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Lac

2005
Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
    The New England journal of medicine, 2001, Dec-20, Volume: 345, Issue:25

    Topics: Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxyge

2001